CoChat
Sign Up
Cited by 290

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Genetic insights in Alzheimer's disease

Bettens, Karolien, Sleegers, Kristel, Van Broeckhoven, Christine·2013·The Lancet Neurology
DOI 10.1016/s1474-4422(12)70259-4
Open this paper in CoChat — free account

Abstract

In the search for new genes in Alzheimer's disease, classic linkage-based and candidate-gene-based association studies have been supplanted by exome sequencing, genome-wide sequencing (for mendelian forms of Alzheimer's disease), and genome-wide association studies (for non-mendelian forms). The identification of new susceptibility genes has opened new avenues for exploration of the underlying disease mechanisms. In addition to detecting novel risk factors in large samples, next-generation sequencing approaches can deliver novel insights with even small numbers of patients. The shift in focus towards translational studies and sequencing of individual patients places each patient's biomaterials as the central unit of genetic studies. The notional shift needed to make the patient central to genetic studies will necessitate strong collaboration and input from clinical neurologists.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(12)70259-4

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 102

  1. Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI
  2. Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch Gen Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 · DOI · Paper page
  3. Hollingworth, 2011, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease, Nat Genet, 43, 429, 10.1038/ng.803 · DOI · Paper page
  4. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  5. Seshadri, 2010, Genome-wide analysis of genetic loci associated with Alzheimer disease, JAMA, 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  6. Kasuga, 2009, Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease, J Neurol Neurosurg Psychiatry, 80, 1050, 10.1136/jnnp.2008.161703 · DOI
  7. Rovelet-Lecrux, 2006, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nat Genet, 38, 24, 10.1038/ng1718 · DOI
  8. Rovelet-Lecrux, 2007, APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage, J Neurol Neurosurg Psychiatry, 78, 1158, 10.1136/jnnp.2006.113514 · DOI
  9. Sleegers, 2006, APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy, Brain, 129, 2977, 10.1093/brain/awl203 · DOI
  10. Di Fede, 2009, A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis, Science, 323, 1473, 10.1126/science.1168979 · DOI
  11. Tomiyama, 2008, A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia, Ann Neurol, 63, 377, 10.1002/ana.21321 · DOI
  12. Hooli, 2012, Role of common and rare APP DNA sequence variants in Alzheimer disease, Neurology, 78, 1250, 10.1212/WNL.0b013e3182515972 · DOI · Paper page
  13. De Strooper, 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, 391, 387, 10.1038/34910 · DOI · Paper page
  14. Bentahir, 2006, Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms, J Neurochem, 96, 732, 10.1111/j.1471-4159.2005.03578.x · DOI
  15. Kumar-Singh, 2006, Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40, Hum Mutat, 27, 686, 10.1002/humu.20336 · DOI
  16. Bickeboller, 1997, Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex, Am J Hum Genet, 60, 439
  17. Genin, 2011, APOE and Alzheimer disease: a major gene with semi-dominant inheritance, Mol Psychiatry, 16, 903, 10.1038/mp.2011.52 · DOI · Paper page
  18. Satake, 2009, Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease, Nat Genet, 41, 1303, 10.1038/ng.485 · DOI
  19. Simon-Sanchez, 2009, Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nat Genet, 41, 1308, 10.1038/ng.487 · DOI · Paper page
  20. Van Deerlin, 2010, Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions, Nat Genet, 42, 234, 10.1038/ng.536 · DOI · Paper page
  21. Guerreiro, 2012, Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease, Neurobiol Aging, 33, 1008, 10.1016/j.neurobiolaging.2011.10.009 · DOI · Paper page
  22. Johnson, 2010, Exome sequencing reveals VCP mutations as a cause of familial ALS, Neuron, 68, 857, 10.1016/j.neuron.2010.11.036 · DOI · Paper page
  23. Watts, 2007, Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia, Clin Genet, 72, 420, 10.1111/j.1399-0004.2007.00887.x · DOI
  24. Rademakers, 2003, Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in western Europe, Hum Mutat, 22, 409, 10.1002/humu.10269 · DOI
  25. Dermaut, 2004, A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques, Ann Neurol, 55, 617, 10.1002/ana.20083 · DOI
  26. Brouwers, 2007, Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family, Arch Neurol, 64, 1436, 10.1001/archneur.64.10.1436 · DOI
  27. Brouwers, 2008, Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease, Neurology, 71, 656, 10.1212/01.wnl.0000319688.89790.7a · DOI
  28. Majounie, 2012, Repeat expansion in C9ORF72 in Alzheimer's disease, N Engl J Med, 366, 283, 10.1056/NEJMc1113592 · DOI
  29. Pottier, 2012, High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease, Mol Psychiatry, 17, 875, 10.1038/mp.2012.15 · DOI · Paper page
  30. Bettens, 2008, SORL1 is geneticaly associated with increased risk for late-onset Alzheimer's disease in the Belgian population, Hum Mutat, 29, 769, 10.1002/humu.20725 · DOI
  31. Reitz, 2010, Meta-analysis of the association between variants in SORL1 and Alzheimer's disease, Arch Neurol, 68, 99, 10.1001/archneurol.2010.346 · DOI · Paper page
  32. Rogaeva, 2007, The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease, Nat Genet, 39, 168, 10.1038/ng1943 · DOI · Paper page
  33. Valdmanis, 2009, A mutation that creates a pseudoexon in SOD1 causes familial ALS, Ann Hum Genet, 73, 652, 10.1111/j.1469-1809.2009.00546.x · DOI
  34. Theuns, 2006, Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease, Am J Hum Genet, 78, 936, 10.1086/504044 · DOI
  35. Bettens, 2012, Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk, Mol Neurodegen, 7, 3, 10.1186/1750-1326-7-3 · DOI
  36. Cirulli, 2010, Screening the human exome: a comparison of whole genome and whole transcriptome sequencing, Genome Biol, 11, R57, 10.1186/gb-2010-11-5-r57 · DOI
  37. van der Zee, 2012, A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability and intermediate repeats, Hum Mutat
  38. Hu, 2011, Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease, PLoS One, 6, e16616, 10.1371/journal.pone.0016616 · DOI
  39. Jun, 2010, Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes, Arch Neurol, 67, 1473, 10.1001/archneurol.2010.201 · DOI · Paper page
  40. Kamboh, 2010, Association of CLU and PICALM variants with Alzheimer's disease, Neurobiol Aging, 33, 518, 10.1016/j.neurobiolaging.2010.04.015 · DOI
  41. Lee, 2011, Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals, Arch Neurol, 68, 320, 10.1001/archneurol.2010.292 · DOI · Paper page
  42. Schjeide, 2011, The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels, Arch Gen Psychiatry, 68, 207, 10.1001/archgenpsychiatry.2010.196 · DOI
  43. Wijsman, 2011, Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE, PLoS Genet, 7, e1001308, 10.1371/journal.pgen.1001308 · DOI
  44. Zhang, 2010, Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease, Brain Res, 1348, 216, 10.1016/j.brainres.2010.06.018 · DOI
  45. Schnetz-Boutaud, 2012, Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene, Ann Hum Genet, 76, 448, 10.1111/j.1469-1809.2012.00727.x · DOI
  46. Antunez, 2011, The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease, Genome Med, 3, 33, 10.1186/gm249 · DOI
  47. Carrasquillo, 2011, Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study, Mol Neurodegener, 6, 54, 10.1186/1750-1326-6-54 · DOI
  48. Ross, 2011, Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study, Lancet Neurol, 10, 898, 10.1016/S1474-4422(11)70175-2 · DOI
  49. Nilselid, 2006, Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms, Neurochem Int, 48, 718, 10.1016/j.neuint.2005.12.005 · DOI · Paper page
  50. Szymanski, 2011, Alzheimer's risk variants in the Clusterin gene are associated with alternative splicing, Transl Psychiatr, 1, e18, 10.1038/tp.2011.17 · DOI
  51. Guerreiro, 2010, Genetic variability in CLU and its association with Alzheimer's Disease, PLoS One, 5, e9510, 10.1371/journal.pone.0009510 · DOI
  52. Thambisetty, 2010, Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease, Arch Gen Psychiatry, 67, 739, 10.1001/archgenpsychiatry.2010.78 · DOI · Paper page
  53. Schrijvers, 2011, Plasma clusterin and the risk of Alzheimer disease, JAMA, 305, 1322, 10.1001/jama.2011.381 · DOI · Paper page
  54. IJsselstijn, 2011, Serum clusterin levels are not increased in presymptomatic Alzheimer's disease, J Proteome Res, 10, 2006, 10.1021/pr101221h · DOI
  55. Schürmann, 2011, Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration, J Alzheimers Dis, 25, 421, 10.3233/JAD-2011-110251 · DOI
  56. Allen, 2012, Novel late-onset Alzheimer disease loci variants associate with brain gene expression, Neurology, 79, 221, 10.1212/WNL.0b013e3182605801 · DOI
  57. Lambert, 2011, Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations, Neurobiol Aging, 32, 756, 10.1016/j.neurobiolaging.2010.11.022 · DOI
  58. Lupton, 2011, Deep sequencing of the nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease, PLoS One, 6, e17298, 10.1371/journal.pone.0017298 · DOI
  59. Dermaut, 2002, The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample, Am J Hum Genet, 70, 1568, 10.1086/340732 · DOI
  60. Hamilton, 2012, Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus, Neurobiol Aging, 33, 1848, 10.1016/j.neurobiolaging.2012.02.005 · DOI
  61. Liang, 2001, Structural organization of the human MS4A gene cluster on chromosome 11q12, Immunogenetics, 53, 357, 10.1007/s002510100339 · DOI
  62. de Silva, 1990, A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins, J Biol Chem, 265, 13240, 10.1016/S0021-9258(19)38290-0 · DOI
  63. Kim, 2008, Role of ATP-binding cassette transporters in brain lipid transport and neurological disease, J Neurochem, 104, 1145, 10.1111/j.1471-4159.2007.05099.x · DOI
  64. Khera, 2009, Complement Receptor 1: disease associations and therapeutic implications, Mol Immunol, 46, 761, 10.1016/j.molimm.2008.09.026 · DOI
  65. Jehle, 2006, ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages, J Cell Biol, 174, 547, 10.1083/jcb.200601030 · DOI
  66. Jones, 2010, Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease, Biochim Biophys Acta, 1801, 754, 10.1016/j.bbalip.2010.04.005 · DOI
  67. Ivanov, 2006, Putative dual role of ephrin-Eph receptor interactions in inflammation, IUBMB Life, 58, 389, 10.1080/15216540600756004 · DOI
  68. Tebar, 1999, Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic, Mol Biol Cell, 10, 2687, 10.1091/mbc.10.8.2687 · DOI · Paper page
  69. Wigge, 1997, Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis, Mol Biol Cell, 8, 2003, 10.1091/mbc.8.10.2003 · DOI
  70. Tateno, 2007, Distinct endocytic mechanisms of CD22 (siglec-2) and siglec-F reflect roles in cell signaling and innate immunity, Mol Cell Biol, 27, 5699, 10.1128/MCB.00383-07 · DOI
  71. Lynch, 2003, A cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton, J Biol Chem, 278, 21805, 10.1074/jbc.M211407200 · DOI
  72. Nuutinen, 2009, Clusterin: a forgotten player in Alzheimer's disease, Brain Res Rev, 61, 89, 10.1016/j.brainresrev.2009.05.007 · DOI · Paper page
  73. Hazrati, 2012, Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism, Neurobiol Aging, 33, e5, 10.1016/j.neurobiolaging.2012.07.001 · DOI
  74. Keenan, 2012, A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline, Hum Mol Genet, 21, 2377, 10.1093/hmg/dds054 · DOI
  75. Harel, 2008, Evidence for CALM in directing VAMP2 trafficking, Traffic, 9, 417, 10.1111/j.1600-0854.2007.00694.x · DOI · Paper page
  76. Lambert, 2010, Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis, J Alzheimers Dis, 20, 1107, 10.3233/JAD-2010-100018 · DOI · Paper page
  77. Thambisetty, 2008, Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease, J Neurol, 255, 1712, 10.1007/s00415-008-0006-8 · DOI
  78. Kok, 2011, CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques, Alzheimers Res Ther, 3, 12, 10.1186/alzrt71 · DOI
  79. Chibnik, 2011, CR1 is associated with amyloid plaque burden and age-related cognitive decline, Ann Neurol, 69, 560, 10.1002/ana.22277 · DOI · Paper page
  80. Kauwe, 2011, Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease, PLoS One, 6, e15918, 10.1371/journal.pone.0015918 · DOI
  81. Kim, 2011, Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort, Neurology, 76, 69, 10.1212/WNL.0b013e318204a397 · DOI · Paper page
  82. Shulman, 2011, Functional screening of Alzheimer pathology genome-wide association signals in Drosophila, Am J Hum Genet, 88, 232, 10.1016/j.ajhg.2011.01.006 · DOI
  83. Braskie, 2011, Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults, J Neurosci, 31, 6764, 10.1523/JNEUROSCI.5794-10.2011 · DOI
  84. Lancaster, 2011, Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene, Eur Neuropsychopharmacol, 21, 880, 10.1016/j.euroneuro.2011.02.001 · DOI
  85. Erk, 2011, Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant, J Neurosci, 31, 18180, 10.1523/JNEUROSCI.4960-11.2011 · DOI
  86. Bralten, 2011, CR1 genotype is associated with entorhinal cortex volume in young healthy adults, Neurobiol Aging, 32, 2106.e7, 10.1016/j.neurobiolaging.2011.05.017 · DOI
  87. Thambisetty, 2012, Alzheimer risk variant CLU and brain function during aging, Biol Psychiatry
  88. Shen, 2010, Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort, Neuroimage, 53, 1051, 10.1016/j.neuroimage.2010.01.042 · DOI
  89. Furney, 2010, Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease, Mol Psychiatry, 16, 1130, 10.1038/mp.2010.123 · DOI · Paper page
  90. Stein, 2012, Identification of common variants associated with human hippocampal and intracranial volumes, Nat Genet, 44, 552, 10.1038/ng.2250 · DOI
  91. Burkhardt, 2008, Common SNPs in HMGCR in Micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13, Arterioscler Thromb Vasc Biol, 28, 2078, 10.1161/ATVBAHA.108.172288 · DOI
  92. Kathiresan, 2008, Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, Nat Genet, 40, 189, 10.1038/ng.75 · DOI · Paper page
  93. Hong, 2009, Strategies and issues in the detection of pathway enrichment in genome-wide association studies, Hum Genet, 126, 289, 10.1007/s00439-009-0676-z · DOI
  94. Hong, 2011, Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease, Hum Mutat, 33, 521, 10.1002/humu.22009 · DOI
  95. Lambert, 2012, Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease, Mol Psychiatry
  96. Barral, 2012, Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory, Neurology, 78, 1464, 10.1212/WNL.0b013e3182553c48 · DOI
  97. Farrer, 2003, Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community, Hum Mol Genet, 12, 415, 10.1093/hmg/ddg037 · DOI
  98. Nalls, 2009, Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease, Neurogenetics, 10, 183, 10.1007/s10048-009-0182-4 · DOI
  99. Sims, 2011, No evidence that extended tracts of homozygosity are associated with Alzheimer's disease, Am J Med Genet B Neuropsychiatr Genet, 156B, 764, 10.1002/ajmg.b.31216 · DOI
  100. Heinzen, 2010, Genome-wide scan of copy number variation in late-onset Alzheimer's disease, J Alzheimers Dis, 19, 69, 10.3233/JAD-2010-1212 · DOI
  101. Shaw, 2011, Olfactory copy number association with age at onset of Alzheimer disease, Neurology, 76, 1302, 10.1212/WNL.0b013e3182166df5 · DOI
  102. Zou, 2012, Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants, PLoS Genet, 8, e1002707, 10.1371/journal.pgen.1002707 · DOI

Cited by

Sorted by citations

Metadata

Authors
Bettens, K., Sleegers, K., & Van Broeckhoven, C.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2013-01
Volume
12
Issue
1
Pages
92-104
ISSN
1474-4422
DOI
10.1016/s1474-4422(12)70259-4
Cited by
290
References
26
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review